GUTS
GUTS clinical trials: FRACTYL HEALTH, INC.
Every trial on ClinicalTrials.gov where FRACTYL HEALTH, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 7
- As lead sponsor
- 2
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
GUTS on the catalyst calendar · GUTS registry changes
- Primary completion Feb 15, 2027Sponsor estimateNo phase registeredNCT06484114Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15%...Fractyl Health Inc. · ObesityActive, not recruitingGUTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2026Sponsor estimateNo phase registeredNCT04419779Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 DiabetesFractyl Health Inc. · Type 2 DiabetesSuspendedGUTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 1, 2028Sponsor estimateNo phase registeredNCT06256497A Prospective Study to Evaluate Revita DMR Post Market Pilot Clinical Follow-Up Registry in Patient With Type 2 DiabetesFractyl Health Inc. · Diabetes Mellitus, Type 2SuspendedGUTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 10, 2020ActualNo phase registeredNCT03653091Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 DiabetesFractyl Health Inc. · Type 2 DiabetesCompletedGUTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 20, 2019ActualNo phase registeredNCT02879383Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)Fractyl Health Inc. · Diabetes Mellitus, Type 2CompletedGUTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 12, 2017ActualNo phase registeredNCT02413567Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 DiabetesFractyl Health Inc. · Diabetes Mellitus, Type 2CompletedGUTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 7, 2017ActualNo phase registeredNCT01927562Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 DiabetesFractyl Health Inc. · Type II DiabetesCompletedGUTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 1, 2027Sponsor estimateNo phase registeredNCT06092476Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes PatientsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Diabetes Mellitus, Type 2Active, not recruitingGUTSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2020ActualNo phase registeredNCT03536650Effect of DMR in the Treatment of NASHErasme University Hospital · NASH - Nonalcoholic SteatohepatitisCompletedGUTSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner